“…At 3 weeks post-Resiquimod treatment, which is presumably the peak of infiltration of adaptive immune aggressors, we observed a modest increase in total immune cell numbers in the heart, with a clear lymphocyte dominance, especially B-cells, in both total and relative numbers. Importantly, both B- and T-cells are important pathogenic components of several autoimmune diseases, including SLE, type-1 diabetes and rheumatoid arthritis ( Askanas et al, 1994 ; Dosreis, 1999 ; Koo et al, 2013 ; Lafyatis et al, 2007 ; Sun et al, 2013 ). However, the role of B-cells in autoimmune disorders varies: in type-1 diabetes, they are predominantly professional antigen-presenting cells ( Dörner et al, 2011 ; Serreze and Silveira, 2003 ; Wong et al, 2004 ), whereas in SLE and rheumatoid arthritis, B-cells contribute to pathology by auto-antibody production ( Dörner et al, 2011 ; Marston et al, 2010 ).…”